UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma

PloS one, 2020-08, Vol.15 (8), p.e0238251-e0238251

2020

Volltextzugriff (PDF)

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis

PloS one, 2019-11, Vol.14 (11), p.e0225482-e0225482

2019

Volltextzugriff (PDF)

Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2007-11, Vol.133 (5), p.1437-1444

2007

Volltextzugriff (PDF)

Novel urine cell-free DNA methylation markers for hepatocellular carcinoma

Scientific reports, 2023-12, Vol.13 (1), p.21585-21585, Article 21585

2023

Volltextzugriff (PDF)

Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations

Journal of biomedical science, 2018-06, Vol.25 (1), p.51-12, Article 51

2018

Volltextzugriff (PDF)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

PloS one, 2021-05, Vol.16 (5), p.e0251552-e0251552

2021

Volltextzugriff (PDF)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

BMC infectious diseases, 2022-04, Vol.22 (1), p.351-9, Article 351

2022

Volltextzugriff (PDF)

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

Frontiers in immunology, 2017-05, Vol.8, p.621-621

2017

Volltextzugriff (PDF)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Viruses, 2022-08, Vol.14 (8), p.1812

2022

Volltextzugriff (PDF)

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Journal of hepatology, 2014-11, Vol.61 (5), p.984-993

2014

Volltextzugriff (PDF)

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

PloS one, 2012-07, Vol.7 (7), p.e41931-e41931

2012

Volltextzugriff (PDF)

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Journal of hepatology, 2009-02, Vol.50 (2), p.289-295

2009

Volltextzugriff (PDF)

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Cellular microbiology, 2017-04, Vol.19 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

PloS one, 2013-11, Vol.8 (11), p.e80053-e80053

2013

Volltextzugriff (PDF)

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer

Cell communication and signaling, 2023-07, Vol.21 (1), p.172-172, Article 172

2023

Volltextzugriff (PDF)

Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage

Cancers, 2018-11, Vol.10 (11), p.460

2018

Volltextzugriff (PDF)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma

Cells (Basel, Switzerland), 2021-05, Vol.10 (6), p.1294

2021

Volltextzugriff (PDF)

Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan

Journal of the Formosan Medical Association, 2021-03, Vol.120 (3), p.983-990

2021

Volltextzugriff (PDF)

Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients

Diagnostics (Basel), 2021-08, Vol.11 (8), p.1475

2021

Volltextzugriff (PDF)

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Cancers, 2023-01, Vol.15 (3), p.854

2023

Volltextzugriff (PDF)

Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma

PloS one, 2012-04, Vol.7 (4), p.e35789-e35789

2012

Volltextzugriff (PDF)

Viral dynamics of persistent hepatitis C virus infection in high-sensitive reporter cells resemble patient’s viremia

Journal of microbiology, immunology and infection, 2018-08, Vol.51 (4), p.446-455

2018

Volltextzugriff (PDF)

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss

Microorganisms (Basel), 2021-05, Vol.9 (6), p.1146

2021

Volltextzugriff (PDF)

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma

Pharmaceutics, 2022-10, Vol.14 (11), p.2263

2022

Volltextzugriff (PDF)

Impact of increasing alanine aminotransferase levels within normal range on incident diabetes

Journal of the Formosan Medical Association, 2012-04, Vol.111 (4), p.201-208

2012

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(86)

Sprache

Englisch
(86)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Humans
(54)
Life Sciences & Biomedicine
(53)
Male
(38)
Female
(33)
Middle Aged
(30)
Adult
(23)
Aged
(19)
Hepatitis
(18)
Hepatocellular Carcinoma
(16)
Hepatitis B
(15)
Liver Cancer
(15)
Antiviral Agents - Therapeutic Use
(14)
Biological And Medical Sciences
(14)
Gastroenterology & Hepatology
(14)
Multidisciplinary Sciences
(14)
Patients
(14)
Science & Technology - Other Topics
(14)
Gastroenterology And Hepatology
(12)
Hepatitis B, Chronic - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis

Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B

Novel urine cell-free DNA methylation markers for hepatocellular carcinoma

Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer

Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma

Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan

Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma

Viral dynamics of persistent hepatitis C virus infection in high-sensitive reporter cells resemble patient’s viremia

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma

Impact of increasing alanine aminotransferase levels within normal range on incident diabetes

Aktive Filter

Suchergebnisse filtern